GET DAILY SIGNALSCrocs (CROX) Analysts Eye $175 Target, Suggesting +15% Upside From Current Levels
Key Takeaways
- The central price target of $175 is the arithmetic mean of the seven current analyst price targets that sit above the latest share price, not a published consensus figure.
- Including all 11 verified targets (range roughly $128 to $190), the overall mean is about $162 — but that average was pulled lower by a single Sell-rated $128 target and would have implied less than a 10% move.
- With the stock near $151.86, reaching $175 requires a gain of roughly 15%, a substantial move from current levels.
- Supporting factors include a third-quarter 2026 earnings beat, raised full-year guidance, HEYDUDE's return to growth, and an undemanding forward valuation.
- The biggest risks are a lingering Sell rating from Goldman Sachs, softness in North America, and uncertainty over whether the HEYDUDE turnaround is durable.
- For more on this company's Major News, Today's Price Move, Forecast, and Earnings, explore the dedicated pages.
Analyst Price Targets and the Consensus Picture
Crocs, Inc. (CROX), the Broomfield, Colorado-based casual footwear maker behind the Crocs and HEYDUDE brands, draws coverage from more than a dozen sell-side analysts. I reviewed 11 current, attributable price targets spanning roughly $128 to $190. Their overall average comes in at about $162, which sits at only a mid-single-digit premium to the latest share price.
Because that broader mean falls short of a meaningful 10% threshold above the current price, the central target instead reflects the average of the seven targets above the share price: Barclays ($178), Baird ($173), Piper Sandler ($170), Williams Trading ($184), BTIG ($190), Bank of America ($160), and Seaport Global ($160). That average rounds to $175, the figure used throughout this piece. The full range of $128 to $190 highlights unusually wide disagreement among analysts.
Views remain split. Bullish analysts highlight improving brand momentum and margin upside. Barclays' Adrienne Yih raised her target to $178, Baird's Jonathan Komp to $173, and Williams Trading's Sam Poser to $184 after the third-quarter report. BTIG's Tom Nikic lifted his target to $190. On the other side, Goldman Sachs' Brooke Roach held a Sell rating while raising her target to $128, while Stifel ($148) and UBS ($145) stay on the sidelines with Hold ratings. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Current Market Position and the Path to the Target
The stock traded around $151.86 in early November 2026, up sharply from its 52-week low near $73 but still below its recent high above $161. Reaching $175 would require an advance of about 15%, a substantial move. The path looks more credible than it did earlier in the year because of a clear fundamental catalyst: on October 29, the company reported third-quarter adjusted earnings per share (EPS) of $3.69, well above the roughly $3.31 consensus, on revenue of about $1.04 billion. Shares jumped more than 25% in a single session.
The company raised its full-year 2026 revenue outlook to roughly 3% growth, up from 1% to 2%, and lifted adjusted EPS guidance to $14.45–$14.65 from $13.70–$14.00. With a forward price-to-earnings (P/E) ratio in the single digits, the valuation leaves room for multiple expansion if earnings momentum continues.
Factors That Could Support a Move Toward the Target
- Earnings momentum: The Q3 beat and raised guidance provide a firmer base for analyst estimate revisions higher.
- HEYDUDE inflection: The brand returned to growth (up 6%), including 14% wholesale growth, supporting the thesis that a key drag is fading.
- International strength: Crocs' international revenue rose double digits, with international direct-to-consumer up 24%.
- Valuation: A low forward P/E and robust free cash flow underpin buybacks, which reduce the share count and support EPS.
Factors That Could Keep the Target Out of Reach
- Bearish dissent: Goldman Sachs' Sell rating and $128 target signal skepticism that recent growth is sustainable.
- North America softness: Domestic demand remains the weakest part of the business, and a consumer slowdown could reverse momentum.
- HEYDUDE durability: The brand's recovery is early, and its turnaround could stall.
- Macro and tariff risk: Footwear is exposed to tariffs, input costs, and discretionary spending shifts.
Technical Levels and Market Structure
The stock sits well above its 50-day and 200-day moving averages after the post-earnings surge, reflecting a firmly bullish longer-term trend. The recent high near $161–$162 marks a clear resistance level that must be cleared before the $175 target comes into view, while the area around $140–$145, where shares consolidated before earnings, provides support. The $150 round number is also a psychological level traders are watching. From what I see, these levels help frame the risk-reward profile clearly.
Time Horizon and What Investors Should Monitor
Analyst price targets generally reflect a roughly 12-month research horizon, though individual firms differ. Investors should watch upcoming quarterly earnings and guidance, any revisions from firms with bullish targets, HEYDUDE's growth trajectory, and consumer-spending and tariff developments. The wide $128-to-$190 target range means estimate revisions will be a key signal of whether the Street's optimism is broadening. I'm watching this closely for signs of broadening conviction.
AI Daily Buy/Sell Signals
Tickeron's AI Daily Buy/Sell Signals use artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals from changing market conditions, technical behavior, and AI-driven analysis. Rather than relying on a single indicator, the system helps traders discover opportunities, monitor positions, and spot shifting trends more efficiently. For investors tracking a fast-moving name like Crocs (CROX), this type of signal can complement fundamental research and provide a more timely read on momentum. I often find these signals useful when cross-checking short-term momentum against longer-term fundamental views.
Final Assessment
Crocs reaching $175 is a substantial but not extreme ask — roughly 15% above recent levels — and it rests on a genuine, if divided, set of analyst views. The target is the average of the seven current targets above the share price, while the broader 11-analyst mean is only about $162 and the range stretches from $128 to $190, underscoring how far apart the bull and bear cases remain. A beaten earnings estimate, raised guidance, HEYDUDE's revival, and a low valuation support the upside case, while Goldman Sachs' Sell rating, North American softness, and turnaround risk are the principal obstacles. Future earnings prints and analyst revisions will be the clearest signposts on whether the move is achievable.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
Momentum Indicator for CROX turns positive, indicating new upward trend
CROX saw its Momentum Indicator move above the 0 level on October 14, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 79 similar instances where the indicator turned positive. In 66 of the 79 cases, the stock moved higher in the following days. The odds of a move higher are at 84%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Moving Average Convergence Divergence (MACD) for CROX just turned positive on October 15, 2026. Looking at past instances where CROX's MACD turned positive, the stock continued to rise in 31 of 45 cases over the following month. The odds of a continued upward trend are 69%.
CROX moved above its 50-day moving average on October 28, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for CROX crossed bullishly above the 50-day moving average on October 23, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 15 of 21 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 71%.
Following a +4.38% 3-day Advance, the price is estimated to grow further. Considering data from situations where CROX advanced for three days, in 201 of 272 cases, the price rose further within the following month. The odds of a continued upward trend are 74%.
The Aroon Indicator entered an Uptrend today. In 143 of 212 cases where CROX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 67%.
Bearish Trend Analysis
The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 6 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 5 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CROX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 77%.
CROX broke above its upper Bollinger Band on October 29, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron SMR rating for this company is 25 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 35 (best 1 - 100 worst), indicating steady price growth. CROX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 41 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: CROX's P/B Ratio (5.258) is slightly higher than the industry average of (2.998). P/E Ratio (13.403) is within average values for comparable stocks, (12.296). Projected Growth (PEG Ratio) (0.030) is also within normal values, averaging (0.949). Dividend Yield (0.067) settles around the average of (0.057) among similar stocks. P/S Ratio (1.460) is also within normal values, averaging (1.162).
The Tickeron Profit vs. Risk Rating rating for this company is 84 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CROX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock better than average.
The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron PE Growth Rating for this company is 91 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a retailer of footwear for men, women and children
Industry WholesaleDistributors
Advertisement